Dmitry Karshtedt

Dmitry Karshtedt
Title:
Associate Professor of Law
Address:
2000 H Street, NW
Washington, District Of Columbia 20052
Phone:
202-994-5725
Email:
dkarshtedt@law.gwu.edu

Dmitry Karshtedt's legal scholarship has appeared in the Vanderbilt Law ReviewWashington University Law Review, and Boston College Law Review and was cited in three of the leading patent law casebooks. Professor Karshtedt's academic work has won several awards, including the scholarship grant for judicial clerks sponsored by the University of Houston Law Center Institute for Intellectual Property and Information Law, the Samsung-Stanford Patent Prize, and the Intellectual Property Writing Competition at Stanford Law School.

Before going into law, Professor Karshtedt completed a Ph.D. in chemistry from U.C. Berkeley and worked as a staff scientist for a semiconductor materials startup. He is a co-author on five scientific publications and a co-inventor on ten U.S. patents. Professor Karshtedt received his law degree from Stanford Law School, where he served as the Senior Symposium Editor for the Stanford Law Review. Professor Karshtedt practiced in the Patent Counseling and Innovation Group at Wilson Sonsini Goodrich & Rosati and clerked for the Honorable Kimberly A. Moore on the U.S. Court of Appeals for the Federal Circuit. Immediately prior to starting his position at GW, Professor Karshtedt was a Fellow at the Center for Law and the Biosciences at Stanford Law School.

Curriculum Vitae     Publications

Education

AB, Harvard University; Ph.D., U.C. Berkeley; JD, Stanford University

In the News

"Allergan Has Made an Unorthodox Agreement with an American Indian Tribe to Fend Off Competition for Its Key Product"

September 08, 2017

Dmitry Karshtedt is quoted in MarketWatch regarding the patents on a key Allergan product, the dry eye medication Restasis.

Brief of Professor Dmitry Karshtedt as Amicus Curiae Supporting Petitioner

August 31, 2017

Dmitry Karshtedt filed an amicus brief in a patent case at the Supreme Court.

"Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars?"

May 10, 2017

Dmitry Karshtedt is quoted in Intellectual Property Watch about a case decided on June 12, 2017 involving biosimilar insulin.